SciELO - Scientific Electronic Library Online

 
vol.27 número2MECHANICAL COMPARISON OF TWO INTERNAL RIGID FIXATION SYSTEMS USED FOR FIXING FACIAL FRACTURES (AN IN VITRO STUDY) índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista Facultad de Odontología Universidad de Antioquia

versão impressa ISSN 0121-246X

Rev Fac Odontol Univ Antioq vol.27 no.2 Medellín jan./jul. 2016

https://doi.org/10.17533/udea.rfo.v27n2a1 

Original article

A SURVIVAL RATE OF ORAL SQUAMOUS CELL CARCINOMA PATIENTS TREATED FOR THE FIRST TIME IN CANCER CENTERS BETWEEN 2000 AND 2011, MEDELLÍN-COLOMBIA *

Adriana Posada-López2  ** 

Marta Aída Palacio3 

Carolina Salas-Z.4 

Efraín Álvarez-M.5 

Hugo Grisales6 

2 School of Dentistry, Universidad de Antioquia, Medellín, Colombia. School of Dentistry, Fundación Universitaria Autónoma de las Américas, Medellín, Colombia.

3 School of Social Work, Universidad Pontificia Bolivariana, Medellín, Colombia.

4 Universidad CES, Medellín, Colombia.

5 School of Dentistry, Universidad de Antioquia, Medellín, Colombia.

6 Facultad Nacional de Salud Pública, Universidad de Antioquia, Medellín, Colombia.


ABSTRACT

Introduction:

the goal of this study is to determine the survival rate of patients white oral squamous cell carcinoma (OSCC) who were treated for the first time in 9 cancer centers over a period of 12 years.

Methods:

analysis of survival rate based on a retrospective sample of 630 cases of oral squamous cell carcinoma (OSCC), according to individual and clinical variables. Relevant life tables were created in order to identify some of the characteristics related to patient survival time; the Kaplan-Meier method, the log Rank test, and the Cox proportional hazards model were used to assess survival significance in relation to relevant variables.

Results:

average patient age at the time of diagnosis was 63.5 years (SD = 13.6 years). 28.1% (177) of them died as a direct consequence of oral cancer, according to death certificates filled out by doctors on duty. Median survival rate was 6.1 years, and when discriminated by sex, age groups, and stage of disease, the median was higher in women, in patients under 50 years of age, and in those who were diagnosed with OSCC in stage I and received surgery as single treatment.

Conclusions:

the survival rate of OSCC patients who were treated for the first time in nine cancer centers of the city of Medellín in a 12-year period was 6.1 years. The authors recommend implementing a surveillance program allowing early diagnosis in order to decrease the sequelae and mortality from this disease.

Key words: oral squamous cell carcinoma; survival rate; epidemiological surveillance

RESUMEN

Introducción:

el objetivo de este estudio fue determinar la supervivencia de los pacientes con cáncer escamocelular bucal (CEB) que fueron tratados por primera vez en 9 centros oncológicos en un periodo de 12 años.

Métodos:

se hizo un análisis de supervivencia basado en una cohorte dinámica retrospectiva de 630 casos de cáncer escamocelular bucal (CEB), según variables de personas y clínicas. Con el fin de identificar algunas características relacionadas con el tiempo de supervivencia de los pacientes, se construyeron las tablas de vida pertinentes; en la valoración de la significación de la supervivencia con respecto a variables de interés, se utilizó el método de Kaplan-Meier, el test de log Rank y el modelo de riesgos proporcionales de Cox.

Resultados:

la edad promedio de los pacientes al momento del diagnóstico fue 63,5 años (DE=13,6 años). El 28,1% (177) de éstos falleció por causa directa del cáncer bucal, de acuerdo con el certificado de defunción diligenciado por el médico de turno. La mediana de supervivencia fue de 6,1 años, y cuando esta se discriminó por sexo, grupos de edad y estadio de la enfermedad, la mediana fue mayor en mujeres, en menores de 50 años, en quienes estaban diagnosticados con CEB en el estadio I y cuyo único tratamiento fue la cirugía.

Conclusiones:

la supervivencia de los pacientes con CEB que fueron tratados por primera vez en nueve centros oncológicos de la ciudad de Medellín en un periodo de 12 años fue de 6,1 años. Se recomienda implementar un programa de vigilancia epidemiológica que permita hacer un diagnóstico precoz con el fin de disminuir las secuelas y la mortalidad por esta enfermedad.

Palabras clave: cáncer escamocelular bucal; supervivencia; vigilancia epidemiológica

INTRODUCTION

Oral cancer causes severe consequences on people′s health, producing physical and functional deformities and mutilations that seriously affect the patients′ psychological, economic, social, and family contexts, as well as their quality of life in general. One of the most common expressions of oral cancer is squamous cell carcinoma (OSCC), a malignant neoplasm resulting from stratified flat epithelium,1)(2) which is scarcely known and is associated with genetic and exogenous factors such as diet, alcohol consumption, smoking, and sun exposure.3) It is widely accepted that tumor location, its clinical stage and treatment type, among other variables, affect patient survival because of its ability to produce significant anatomical and physiological effects in those who suffer from it. (4

Prevalence, incidence, and mortality by OSCC vary widely in different parts of the world, with a high incidence rate in India and South Africa and low frequency in Japan and Mexico, with the aggravating factor of a significant increase among young people5) The literature indicates that a high percentage of OSCC patients are diagnosed in advanced stages (usually stage IV), with an evident decrease in survival probabilities.6) In Colombia in general, and in the city of Medellín in particular, studies including aspects related to OSCC patient survival are scarce. A report from the city of Cali suggests a relative survival rate of 55.5% in five years (CI 95% 50.9-59.9).7

It is therefore necessary to estimate survival rates of OSCC patients from their first treatment (in this case, the estimation was performed in cancer centers in Medellín, Colombia, in the period 2000- 2011) and to explore associated factors, providing prevention and early intervention strategies in order to reduce mortality.

METHODS

This article describes the experience of survival analysis based on a dynamic retrospective sample of OSCC cases treated for the first time in nine specialized cancer centers in Medellín between 2000 and 2011. With the approval of the participating institutions, the authors analyzed the medical histories of patients diagnosed with OSCC as a primary tumor (codes C00 to C06, C10 and C14 of the International Classification of Diseases, version 10, ICD 10), which allowed selecting OSCC patients based on histopathological confirmation, who had been treated for the first time in the nine specialized cancer centers. The medical histories of patients who had received any phase of OSCC treatment at a cancer center outside Medellín were excluded. Information about participating patients was obtained by first reviewing their clinical histories; if this showed that the patient was dead, indicating the cause and date of death, the information that was relevant for the study was collected. In some situations, when there was information of some patients who had died but whose clinical history included no death certificate, their families were contacted in order to find out the cause and date of death. In cases where the medical histories did not report their condition, the patients of their families were contacted in order to collect relevant information. In total, out of the 1700 medical histories manually reviewed, 630 patients were identified as meeting the inclusion criteria. It is worth mentioning that, in the case of living patients, the variable "date of last contact" was created based on information from the last date recorded in their medical history or from phone calls; in the case of deceased patients, the date of death included in the death certificate was assumed. Patients whose families reported not having access to a death certificate were assigned the latest date in which they were attended in the institution. Patients whose status was not possible to validate were assigned the latest date of contact with the institution. The variable "monitoring time" in months was calculated by differentiating the last contact date from the date of first treatment, the condition of no censoring was defined as patient death because of oral cancer during the study period. The data collection instrument was improved based on the suggestions resulting from the pilot test.

Information was recorded in a retrospective manner, taking into account the epidemiological variables of person, time, place, and clinics. Observer bias was controlled with advice by a head and neck oncology surgeon and a maxillofacial surgeon with experience in oral cancer; these two surgeons played a vital role in the instrument design, especially concerning clinical variables. The participating institutions approved telephone contact with all patients and their relatives, in order to verify whether patients were alive or dead. In the latter case, families were requested a death certificate, in order to find out the date and cause of death. This allowed avoiding information and selection bias. A standardized conversation script was used for telephone conversations, which was approved by the bioethics committee of each institution, in order to control information bias. Data were prepared by means of the available procedures, such as error typing detection, declaration of lost values, and variable cross-validation in order to observe the consistency of data related to the study variables. It is worth mentioning that this study defined a single medical history as the result of the compilation of information obtained through review of multiple histories of the same patient, from date of first treatment to date of death.

The statistical analysis was performed by means of the classical univariate indicators of survival. In order to assess the likelihood of patient survival in a given period of time ranging from the moment they were treated for the first time, we used the Kaplan- Meier method and the bivariate examination of survival using the relevant variables, which required implementing the log Rank test. The multivariate analysis required the construction of an explanatory model of Cox proportional hazards, based on the variables that met the Hosmer Lemeshow criterion during the bivariate test, as well as those that the state of the art defines as plausible. The research and bioethics committees of the nine institutions approved the use of informed consent and telephone contact with patients and labeled this research as "risk-free" as it involved no intervention in individuals. The data was processed using version 18 of the SPSS software.

RESULTS

Socio-demographic characteristics and habits

Average age at the time of diagnosis was 63.5 years (SD = 13.6 years). Sex distribution showed that 52.2% of patients were males. 54.3% of patients were originally from the city of Medellín, were they also resided; regarding marital status, 54.5% reported being married; 52.4% came from lower social levels, and 47.6% from medium or high social levels. 26% of patients provided information on their education level; 63.2% of them reported having primary education. As for social security coverage, most patients (66.9%) belonged to the contributory regime as either primary contributors or beneficiaries, followed by 25.3% who were covered by the subsidized regime (Table 1). Out of 546 patients, 45.4% of males were smokers, compared to 27.8% of females, but there was no statistical association (p = 0.168); out of the women who said they smoked cigarettes, 7.2% did so in an inverted manner, that is to say, with the flame inside the mouth, especially those residing in the states of Chocó, Sucre, and Cordoba. None of the men participating in this study referred practicing that type of smoking. In terms of alcohol consumption by 425 patients as stated in their medical histories, 29.1% of men used to drink alcohol compared to 5.6 percent of women, with statistical association (p = 0.000).

Table 1 Socio-demographic characteristics of patients with oral cancer treated for the first time in cancer centers, Medellin, 2012 

Clinical characteristics of patients

The most frequent anatomic locations of tumors were the tongue, the floor of the mouth, and the oropharynx (56, 25.4 and 23.1%, respectively); the distribution of OSCC stage according to location in a single anatomical location indicated that the three abovementioned locations were the most prevalent and were treated for the first time when patients were in stages III and IV (Table 2 and Table 3).

Table 2 Clinical characteristics of oral cancer patients treated for the first time in cancer centers, Medellín, 2012 

Table 3 Distribution of the most frequent location of tumor according to stage in oral cancer patients treated for the first time in cancer centers, Medellín, 2012 

Characteristics of treatment

In total, 53.3% of patients received a combined treatment, as shown in Table 2. The most frequent single treatments were surgery (31.7%) and radiotherapy (10.6%). 4.5% of patients did not receive any treatment. When comparing distribution of treatment and disease stage, we found out that 50% of patients who did not receive any treatment had been diagnosed at stage IV.

In relation to the comprehensive care that patients should receive, 79.8% on average were not referred to other professionals. Those who received additional support were remitted mainly to nutritional care and pain and palliative care (Table 2).

Factors related to patient survival

Out of the analyzed patients, 28.1% (177) died because of OSCC. The median survival rate was 6.1 years (Interquartile Range = 1.6 years); 50% survival time was 6.1 years or less. From the moment of first treatment to before the first 11 months, the cumulative probability of survival was 83%, and about two years after first treatment, this cumulative probability dropped by 20%. Five years later, the cumulative probability of survival by OSCC from the first treatment decreased gradually up to 54%, and from this moment on it behaved in a similar manner.

Statistical differences of patient cumulative survival time were found from the time of first treatment until death by sex, age, stage of tumor, and treatment received, being higher in women, patients younger than 50 years, patients diagnosed at stage I, and those who received surgery as single treatment (p = 0.003, 0.001, 0.000, and 0.001 respectively). Similarly, there were survival rate differences among those who received psychological care, nutritional care, and support for pain and palliative care (p = 0.019, 0.048 and 0.000 respectively). On the other hand, the analysis of clinical variables and treatment showed that the median survival rate varied significantly by tumor stage and treatment type: in the first case, there was an inverse relationship, i.e., the higher the stage the lower the survival probability; in the second case, patients who received surgery as single treatment showed a greater median survival rate than those with any other individual or combined treatment (Table 4).

Table 4 Summary indicators, confidence intervals, and log Rank test for the cumulative survival rate of oral cancer patients treated for the first time in cancer centers, Medellín, 2012 

* Indicates statistically significant differences at a 5%.

** Category of reference

Joint factors related to survival from the time of first treatment to death

Once compliance of proportional hazards were demonstrated, we found out that patients under 50 years old had greater survival rates compared with those older than 50 years, and that being a male represents 1.4 times more risk of dying by OSCC compared to being a female. In terms of tumor stage, we observed that the risk of dying (HR) by oral cancer increases when stage is higher; for example, the risk of dying of a patient diagnosed at stage IV is 3.7 times (CI:1.9-7.2, p = 0.000) compared with someone who is diagnosed at stage I. All other variables remained constant (Table 5).

Table 5 Model of Cox proportional hazards for the cumulative survival rate of oral cancer patients treated for the first time in cancer centers, Medellín, 2012 

Categories of reference: gender: female; age: < 50; stage: I

DISCUSSION

Analyzing a sample of patients diagnosed and treated for OSCC in a period of 12 years (2000-2011) and gathering information for more than half of them from the perspective of survival time allowed us to assess survival rate. Many studies conclude that oral cancer is a chronic disease that primarily affects people older than 65,6as the present study confirms.6)(8

In the present study, the proportion of oral cancer was similar by sex, although some studies suggest that it is higher in males, which could be explained by their types of job;2)(9however, it has been reported that this ratio has been becoming equal, which is explained by changing social behaviors such as increased cigarette and alcohol consumption among women.10)(11Inverted cigarette smoking is considered a risk factor for oral cancer; in this study, 11 women had this characteristic.(3)(5)(12)(13)(14

Patients in this study come mostly from medium and low socio-economic levels, and their maximum education level is primary school, agreeing with several studies which suggest that the most vulnerable population is the one with little education, as it influences self-care for oral health and nutrition, both of which are considered risk factors for oral cancer. 14)(15)(16

In general, the literature reports that oral cancer is diagnosed at advanced stages,17)(18 which is consistent with the data from the analyzed sample, where most patients had a stage IV diagnosis,19)(20) with the tumor lesion located in one place of the mouth, being the tongue the most frequent site, followed by the floor of the mouth and the oropharynx.3)(6 Surgery is the primary treatment,6) despite the fact that in most cases it affects patient′s physiognomy and voice and is considered as aggressive, invasive, and mutilating. In addition, the time between diagnosis and first treatment (for patients whose medical records included this information) was three months, which is lower than the time found in Lopez′s study (1999), in which this disease′s evolution time until treatment averaged 8.5 months.6) A study conducted in 2012 in Manizales, Colombia, on different types of cancer, including that of the oral cavity, found out that patients were treated in average two months after feeling the first symptoms;21this suggests that oral cancer is detected and treated at a later stage, which is not consistent with good clinical practices. 21)(22)(23)(24

Overall survival rate at 5 years is 54%. This result is similar to that of other studies, in which survival rate was 50%,25and to another study which assessed the prognostic factors reporting a survival rate of 43 to 61%.26) Survival was higher in women, in patients under 50 years old, in those who were diagnosed in stage I and in those who received surgery as single treatment. Survival is highly affected by tumor stage; the higher the stage the higher the likelihood of death, which is consistent with studies on the tumor stage as a biological possibility of prognostic factor. 3)(17)(27)(28)(29)(30)(31

Limitations of the present study include the impossibility to check death certificates in government institutions against information from medical records, which reduced the number of patients included in the analysis. In addition, tracking patients through phone calls makes it difficult to analyze the actual phenomenon, requiring the cooperation of government bodies such as the Departamento Administrativo Nacional de Estadística (DANE) to access information of underlying causes and date of death. Another major limitation of this study is that the institutions′ information systems are not designed nor intended for health research, substantially limiting the collection of data on variables that can influence the different phenomena that are of interest to epidemiology; notably, the clinical histories showed an inadequate classification of the disease according to the ICD- 10 by the institutions, creating information bias that goes beyond researchers′ control.

Finally, these results may help health institutions in developing communication and educational strategies on prevention, treatment, and rehabilitation of oral cancer in order to reduce the main risk factors that make of this disease a public health problem. Similarly, the results allow health institutions to document oral cancer patients′ survival rate, to have a more systemic view, and thus to strengthen their capacity for comprehensive care offered to patients and their families. Early diagnosis prevents patients from getting to an advanced stage of the disease threatening their physical integrity; and in terms of the institutions, timely attention allows a better use of resources, as they won′t need to invest in expensive treatments and will prevent lawsuits that affect institutional image. It is recommendable to implement a program of oral epidemiological surveillance since childhood at the local, regional, and national levels, allowing to observe and identify priority health problems, to evaluate interventions and to reevaluate the traditional view that oral diseases include tooth decay and periodontal disease only; In addition, non-dental professionals in the health care system must be sensitized to promptly refer patients with lesions and associated risk factors, as well as those who do not have such risk factors, as many diseases of the mouth are also seen by medical doctors, nurses, and other professionals who just prescribe anesthetics or mouthwashes.

In this situation, dentistry schools are encouraged to recognize that the role of dentists is a determining factor in early detection. They should be trained to contribute to the solution and monitoring of this type of disease. The government has formulated cancer policies; however, political will is required in order to achieve the goals stated, reducing incidence and mortality, and increasing survival rate and patients′ quality of life.

ACKNOWLEDGMENTS

To the nine participating institutions, the social workers who helped in data collection, to the patients and their families, and to the Epidemiology Group of Universidad de Antioquia′s Facultad Nacional de Salud Pública.

CONFLICTS OF INTEREST

The authors report not having any conflicts of interest

REFERENCES

1. Sapp J, Eversole L, Wysocki G. Neoplasias epiteliales malignas. Patol Oral Maxilofac Contemp 2005; 2: 184- 195. [ Links ]

2. Guzmán GP, Villaseca HM, Antonio PL, Araya OJ, Aravena MP, Cravero PC et al. Carcinoma epidermoide oral y orofaríngeo: Estudio clínico-patológico. Rev Chil Cir 2011; 63(3): 250-256. [ Links ]

3. Solano-Mendoza P, García-García V, Bascones-Martínez A. ¿Existe suficiente evidencia en la literatura para considerar el tabaco y el alcohol como principales factores de riesgo del cáncer de lengua? Av Odontoestomatol 2010; 26(1): 31-44. [ Links ]

4. Silvestre-Donat FJ, Puente-Sandoval A. Efectos adversos del tratamiento del cáncer oral. Av Odontoestomatol 2008; 24(1): 111-121. [ Links ]

5. Rodríguez RN, Álvarez BY, Cárdenas PE, Cruz BMC, Morales PMI, Cepero FF. Caracterización de las remisiones del Programa de Detección Precoz del cáncer bucal al segundo nivel de atención en el área norte de Ciego de Ávila. Mediciego 2012; 18 (Supl 1). [ Links ]

6. López-Pizarro VM. Factores pronósticos del carcinoma epidermoide de cavidad oral: Análisis multivariante. Rev Esp Cir Oral Maxilofac 1999; 21(2): 59-70. [ Links ]

7. Bravo L, Ordóñez D, Aragón V. Comportamiento del cáncer oral en Santiago de Cali 1968-2007. En: Simposio de Investigaciones en Salud, XV Simposio de Investigaciones en Salud: Discapacidad y Ciclo Vital; 23 y 24 de octubre de 2013. Cali,Colombia. [ Links ]

8. Álvarez-Martínez E, Preciado-Uribe A, Montoya- Fernández S, Jiménez-Gómez R, Posada-López A. Características clínicas e histopatológicas del carcinoma escamocelular bucal en el periodo 1990-2004 en Medellín, Colombia. Rev Cuba Estomatol 2011; 48(4): 320-329. [ Links ]

9. Mendoza S, García G, Martínez B. ¿Existe suficiente evidencia en la literatura para considerar el tabaco y el alcohol como principales factores de riesgo del cáncer de lengua? Av Odontoestomatol 2010; 26(1): 31-44. [ Links ]

10. Cadena-Piñeros E, Acosta-de Hart Á, Llamas-Olier A. Squamous cell carcinoma of the upper lip in an adolescent patient. Rev Fac Med Univ Nac Colomb. 2011; 59(4): 331- 338. [ Links ]

11. Scully C, Bagan J. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis 2009; 15(6): 388-399. [ Links ]

12. Gaitán C, Peniche B, Quezada R. Tendencias temporales de frecuencia y prevalencia de cáncer oral y carcinoma de células escamosas oral en mexicanos: un estudio retrospectivo de 20 años. Med Oral Patol Oral Cir Bucal 2011; 16(4): 205-209. [ Links ]

13. Álvarez M, Preciado U. Características clínicohistopatológicas del carcinoma escamocelular bucal, Colombia. Rev Cuba Estomatol 2010; 47(1): 81-95. [ Links ]

14. Martínez-Sahuquillo, Márquez A, Gallardo- Castillo I, Cobos-Fuentes M, Caballero-Aguilar J, Bullón-Fernández P. La leucoplasia oral: su implicación como lesión precancerosa. Av Odontoestomatol 2008; 24 (1): 33-44. [ Links ]

15. Buelvas AR, Agudelo AA. Social gradient, aging and delayed diagnosis of oral cancer. Rev Fac Nac Salud Pública 2011; 29(3): 320-328. [ Links ]

16. Ziglio E, Barbosa R, Charpak Y, Turner S (eds). Health systems confront poverty [internet]. Copenhagen: WHO Regional Office for Europe; 2003. 176 p. (Public Health Case Studies Series, No. 1). [Consultado 2016 abr 15]. Disponible en:Disponible en:http://www.euro.who.int/document/ e80225.pdfLinks ]

17. Steele TO, Meyers A. Early detection of premalignant lesions and oral cancer. Otolaryngol Clin North Am 2011; 44(1): 221-229. [ Links ]

18. Fernandes-de-Sena M, Serêjo-da-Costa A, Silva-da- Nóbrega A, Lopes-Costa A, Fernandes-Ferreira M. Evaluación de los factores pronósticos relacionados con el cáncer de labio: revisión sistemática. Rev Bras Cancerol 2010; 56(1): 1-9. [ Links ]

19. Scully C, Bagan JV. Recent advances in oral oncology. Oral Oncol 2007; 43(2): 107-115. [ Links ]

20. Petti S, Scully C. Oral cancer knowledge and awareness: primary and secondary effects of an information leaflet. Oral Oncol 2007; 43(4): 408-415. [ Links ]

21. Villegas CR, Chacón JA, Cardona JP, Correa LÁ. Perfil clínico epidemiológico de los pacientes con cáncer tratados en una institución de tercer nivel. Manizales, Colombia, 1995-2004. Colomb Médica 2012; 43(1): 11-18. [ Links ]

22. Delgado NP, Rousseaux MS. III Congreso Regional de Medicina Familiar Wonca Iberoamericana. CIMF. X Seminario Internacional de Atención Primaria de Salud Versión Virtual Universidad de Ciencias Médicas . Guantánamo, Cuba. 2010. [ Links ]

23. Marcos Á, Pendas JLL, Gutiérrez VF. Recidivas en el cáncer escamoso de cabeza y cuello. Acta Otorrinolaringol Esp 2007; 58(4): 156-163. [ Links ]

24. Mignogna, M. Screening del cáncer oral. Cinco minutos para salvar vidas. RCOE Rev Ilutre Cons Gen Col Odontól Estomatól Esp 2013, 18(2): 115-117. [ Links ]

25. Kujan O, Glenny A, Oliver R, Thakker N, Sloan P. Programas de cribaje (screening) para la detección precoz y la prevención del cáncer oral. Cochrane Database of Systematic Reviews [en línea] 2013: 1-27 URL disponible en:http://onlinelibrary.wiley.com/doi/10.1002/14651858. CD004150.pub4/pdfLinks ]

26. Liuzzi J, Estanga N, Nunez C. Factores pronósticos en el carcinoma de células escamosas de cavidad oral. Rev Venez Oncol 2007; 19(2): 129-134. [ Links ]

27. Mashberg A, Samit AM. Early detection, diagnosis, and management of oral and oropharyngeal cancer. CA Cancer J Clin. 1989; 39(2): 67-88. [ Links ]

28. Bórquez MP, Capdeville FF, Madrid MA, Veloso OM, Cárcamo PM. Sobrevida global y por estadios de 137 pacientes con cáncer intraoral: Experiencia del Instituto Nacional del cáncer. Rev Chil Cir 2011; 63(4): 351-355. [ Links ]

29. Torres-Salcines J. Epidemiología descriptiva y análisis de supervivencia del cáncer de base de lengua en hospitales públicos de Madrid. Tesis Doctoral. Universidad Complutense de Madrid. 2013. [ Links ]

30. Salmerón-Escobar JI, López-Quiles J, Villacieros A, Cerezo-Lapiedra R, Esparza-Gómez G. La mayoría de los cánceres orales se diagnostican en estadios avanzados: cinco expertos analizan la situación del cáncer oral en España. Gac Dent 2013; 253: 70-85. [ Links ]

31. Jiménez-Rodríguez Y, Coca-Granado RM. Factores pronósticos en el carcinoma epidermoide de cabeza y cuello. Acta Med Cent 2013; 7(4): 1-15 [ Links ]

Received: November 19, 2013; Accepted: October 28, 2014

CORRESPONDING AUTHOR Adriana Posada López Facultad de Odontología, Universidad de Antioquia (+574) 219 6740, Fax (+574) 219 6700 adriposalo@gmail.com Calle 70 N.° 52-21 Medellín, Colombia

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License